BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34278168)

  • 1. STE20-Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes.
    Caputo M; Cansby E; Kumari S; Kurhe Y; Nair S; Ståhlman M; Kulkarni NM; Borén J; Marschall HU; Blüher M; Mahlapuu M
    Hepatol Commun; 2021 Jul; 5(7):1183-1200. PubMed ID: 34278168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STE20-type kinase TAOK3 regulates hepatic lipid partitioning.
    Xia Y; Caputo M; Cansby E; Anand SK; Sütt S; Henricsson M; Porosk R; Marschall HU; Blüher M; Mahlapuu M
    Mol Metab; 2021 Dec; 54():101353. PubMed ID: 34634521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of STE20-type kinase TAOK1 confers protection against hepatocellular lipotoxicity through metabolic rewiring.
    Xia Y; Andersson E; Anand SK; Cansby E; Caputo M; Kumari S; Porosk R; Kilk K; Nair S; Marschall HU; Blüher M; Mahlapuu M
    Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36930872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice.
    Caputo M; Andersson E; Xia Y; Hou W; Cansby E; Erikson M; Lind DE; Hallberg B; Amrutkar M; Mahlapuu M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of MAP4K4 signaling initiates metabolic reprogramming to protect hepatocytes from lipotoxic damage.
    Anand SK; Caputo M; Xia Y; Andersson E; Cansby E; Kumari S; Henricsson M; Porosk R; Keuenhof KS; Höög JL; Nair S; Marschall HU; Blüher M; Mahlapuu M
    J Lipid Res; 2022 Jul; 63(7):100238. PubMed ID: 35679904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease.
    Caputo M; Kurhe Y; Kumari S; Cansby E; Amrutkar M; Scandalis E; Booten SL; Ståhlman M; Borén J; Marschall HU; Aghajan M; Mahlapuu M
    FASEB J; 2021 May; 35(5):e21567. PubMed ID: 33891332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STE20-type kinases MST3 and MST4 promote the progression of hepatocellular carcinoma: Evidence from human cell culture and expression profiling of liver biopsies.
    Caputo M; Xia Y; Anand SK; Cansby E; Andersson E; Marschall HU; Königsrainer A; Peter A; Mahlapuu M
    FASEB J; 2023 Aug; 37(8):e23105. PubMed ID: 37490000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GCKIII kinases in lipotoxicity: Roles in NAFLD and beyond.
    Mahlapuu M; Caputo M; Xia Y; Cansby E
    Hepatol Commun; 2022 Oct; 6(10):2613-2622. PubMed ID: 35641240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans.
    Cansby E; Kulkarni NM; Magnusson E; Kurhe Y; Amrutkar M; Nerstedt A; Ståhlman M; Sihlbom C; Marschall HU; Borén J; Blüher M; Mahlapuu M
    FASEB J; 2019 Sep; 33(9):9974-9989. PubMed ID: 31173506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
    Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
    J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
    Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M
    Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
    Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M
    FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSA controls hepatic lipid metabolism by regulating the NRF2 signaling pathway.
    Huang B; Xiong X; Zhang L; Liu X; Wang Y; Gong X; Sang Q; Lu Y; Qu H; Zheng H; Zheng Y
    J Mol Cell Biol; 2021 Oct; 13(7):527-539. PubMed ID: 34048566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate Treadmill Exercise Alleviates NAFLD by Regulating the Biogenesis and Autophagy of Lipid Droplet.
    Yang Y; Li X; Liu Z; Ruan X; Wang H; Zhang Q; Cao L; Song L; Chen Y; Sun Y
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease.
    Liu C; Zhou B; Meng M; Zhao W; Wang D; Yuan Y; Zheng Y; Qiu J; Li Y; Li G; Xiong X; Bian H; Zhang H; Wang H; Ma X; Hu C; Xu L; Lu Y
    J Hepatol; 2021 Jul; 75(1):150-162. PubMed ID: 33548387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans.
    Amrutkar M; Kern M; Nuñez-Durán E; Ståhlman M; Cansby E; Chursa U; Stenfeldt E; Borén J; Blüher M; Mahlapuu M
    Diabetologia; 2016 Feb; 59(2):341-53. PubMed ID: 26553096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis reveals exercise training induced remodelling of hepatokine secretion and uncovers syndecan-4 as a regulator of hepatic lipid metabolism.
    De Nardo W; Miotto PM; Bayliss J; Nie S; Keenan SN; Montgomery MK; Watt MJ
    Mol Metab; 2022 Jun; 60():101491. PubMed ID: 35381388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
    He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
    World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ménage à trois of autophagy, lipid droplets and liver disease.
    Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
    Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.